The mechanism of anti-tumor immunity induced by varlilumab, a CD27 agonist mAb, is model dependent

Detalles Bibliográficos
Autores principales: He, Li-Zhen, Wasiuk, Anna, Testa, James, Weidlick, Jeffrey, Sisson, Crsytal, Crocker, Andrea, Widger, Jenifer, Forsberg, Eirc, Gergel, Lauren, Thomas, Lawrence, Marsh, Henry, Keler, Tibor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649460/
http://dx.doi.org/10.1186/2051-1426-3-S2-P188

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649460/
http://dx.doi.org/10.1186/2051-1426-3-S2-P188

Ejemplares similares